Clinically meaningful benefit and real‐world evidence in Alzheimer's disease research and care
Abstract In the realm of medical research, assessing novel therapies extends beyond statistical significance. The concept of meaningful benefits plays a pivotal role in determining the practical impact of interventions on patient outcomes. Clinical trials, which form the bedrock of evidence‐based me...
Saved in:
| Main Authors: | Robert Perneczky, Lutz Froelich |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/trc2.70090 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Efficacy of Anti-amyloid Monoclonal Antibodies in Early Alzheimer’s Dementia: A Systematic Review
by: Alyaa Mostafa, et al.
Published: (2025-05-01) -
How do we put meaning into meaningful benefit? Perspectives from the lived experience
by: Russ Paulsen, et al.
Published: (2025-04-01) -
The relationship between anticholinergic burden and frailty in the year preceding a diagnosis of dementia with Lewy bodies
by: Kathryn A. Wyman‐Chick, et al.
Published: (2024-10-01) -
The Greek Version of the Mild Behavioral Impairment Checklist (MBI-C): Psychometric Properties in Mild Cognitive Impairment Due to Alzheimer’s Disease
by: Efthalia Angelopoulou, et al.
Published: (2025-04-01) -
A new method for community-based intelligent screening of early Alzheimer’s disease populations based on digital biomarkers of the writing process
by: Shuwu Li, et al.
Published: (2025-06-01)